Group News

A recent study published in Circulation shows that patients who take their medication faithfully have dramatically better long-term outcomes, regardless of whether they have CABG or PCI. However, among the non-adherent group, CABG patients fared better with fewer major adverse cardiac events in the years after surgery. “This study shows how important it is to get to know your patients and find out how well they comply with medication,” says Paul Kurlansky, MD, who led the study and is currently director of research for Columbia HeartSource.
Read More >
NYP/Columbia was among the first to offer patients access to Heartmate 3, the newest LVAD technology, in a clinical trial testing it against current standard of treatment, the Heart Mate II. In a randomized study reported in New England Journal of Medicine and presented at American Heart Association in November 2016, lead investigator Yoshifumi Naka, MD, PhD, reported fewer complications with the Heartmate 3, noting a marked improvement over Heartmate II.
Read More >
What's New in the Department of Surgery

Mini-Sternotomy for a Tortuous Aortic Aneurysm

Read More >
What's New in the Department of Surgery

Pulmonary Vein Stenosis (PVS)

Read More >
The interventional cardiologist or surgeon places the artificial valve in the diseased valve and inflates the balloon
(TAVR)—a minimally invasive method of replacing damaged aortic valves.
Read More >

Pages